Infliximab in the Treatment of Severe Psoriasis Vulgaris
Aisha Altrabulsi, Azza H. Grew & Gamal A. Duweb · Asian Journal of Research in Dermatological Science · 2022
Psoriasis is a chronic, immune mediated inflammatory disease. The inflammatory activity of the psoriasis plaques is partially triggered by activation of the Th1 lymphocytes, which release pro-inflammatory chemokines and cytokines such as tumor necrosis factor alpha (TNF-α). Infli...
Open access
Research Article